
Health Dictionary
Reliable, easy-to-read patient information on common medical conditions β written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
Gastrointestinal varices causes
Introduction
Overview
Overview
Causes of gastointestinal varices include all the causes of increased portal venous pressure, which may be divided into cirrhotic and non-cirrhotic causes.
Causes
Causes
- Gastrointestinal varices (especially esophageal and gastric) are due to increased pressure in the portal venous system
- The major causes of portal hypertension may be broadly categorized into cirrhotic and non-cirrhotic[1][2][3][4][5][6][7][8][9][10][11][12][13][14][15][16][17][18][19][20]
Cirrhotic causes
- Chronic hepatitis (B or C)
Non-cirrhotic causes
Pre-hepatic causes
- Portal vein thrombosis
- Splenic vein thrombosis
- Splanchnic arteriovenous fistula
- Splenomegaly (eg, from lymphoma, Gaucher’s disease)
Intrahepatic causes[1][5][6][7][8][9][10][11][12][13][14][17][18][19][20]
- Presinusoidal:
- Schistosomiasis
- Idiopathic non-cirrhotic portal hypertension (including nodular regenerative hyperplasia)
- Primary biliary cirrhosis
- Sarcoidosis
- Congenital hepatic fibrosis
- Primary sclerosing cholangitis
- Hepatic arteriopetal fistula
- Adult polycystic liver disease
- Arteriovenous fistulas
- Autoimmune cholangiopathy
- Vinyl chloride toxicity
- Neoplastic occlusion of the intra-hepatic portal vein
- Mineral oil granuloma
- Sinusoidal:
- Arsenic poisoning
- Vinyl chloride toxicity
- Drugs (eg, amiodarone, methotrexate)
- Alcoholic liver disease
- Nonalcoholic fatty liver disease
- Gaucher’s disease
- Zellweger syndrome
- Viral hepatitis
- Chronic Q fever
- Schistosomiasis
- Amyloid or light-chain deposition in the space of Disse
- Acute hepatic injury
- Mastocytosis
- Agnogenic myeloid metaplasia
- Acute fatty liver of pregnancy
- Postsinusoidal:
- Sinusoidal obstruction syndrome (venoocclusive disease)
- Budd-Chiari syndrome
- Alcoholic liver disease
- Chronic radiation injury
- Vitamin A toxicity
- Epithelioid hemangioendothelioma
- Angiosarcoma
- Sarcoidosis
- Mycobacterium avium or M. intracellulare infection
- Mineral oil granuloma
- Inferior vena cava (IVC) obstruction (eg, Budd-Chiari syndrome)
- Cardiac disease (constrictive pericarditis, restrictive cardiomyopathy)
References
References
- β 1.0 1.1 Li X, Gao W, Chen J, Tang W (2000). “[Non-cirrhotic portal hypertension associated with autoimmune disease]”. Zhonghua Wai Ke Za Zhi (in Chinese). 38 (2): 101β3. PMIDΒ 11831999.
- β Kono K, Ohnishi K, Omata M, Saito M, Nakayama T, Hatano H, Nakajima Y, Sugita S, Okuda K (1988). “Experimental portal fibrosis produced by intraportal injection of killed nonpathogenic Escherichia coli in rabbits”. Gastroenterology. 94 (3): 787β96. PMIDΒ 3276575.
- β 3.0 3.1 Kumar S, Joshi R, Jain AP (2007). “Portal hypertension associated with sickle cell disease”. Indian J Gastroenterol. 26 (2): 94. PMIDΒ 17558079.
- β 4.0 4.1 Bayan K, TΓΌzΓΌn Y, Yilmaz S, Canoruc N, Dursun M (2009). “Analysis of inherited thrombophilic mutations and natural anticoagulant deficiency in patients with idiopathic portal hypertension”. J. Thromb. Thrombolysis. 28 (1): 57β62. doi:10.1007/s11239-008-0244-8. PMIDΒ 18685811.
- β 5.0 5.1 Girard M, Amiel J, Fabre M, Pariente D, Lyonnet S, Jacquemin E (2005). “Adams-Oliver syndrome and hepatoportal sclerosis: occasional association or common mechanism?”. Am. J. Med. Genet. A. 135 (2): 186β9. doi:10.1002/ajmg.a.30724. PMIDΒ 15832360.
- β 6.0 6.1 Maida I, Garcia-Gasco P, Sotgiu G, Rios MJ, Vispo ME, Martin-Carbonero L, Barreiro P, Mura MS, Babudieri S, Albertos S, Garcia-Samaniego J, Soriano V (2008). “Antiretroviral-associated portal hypertension: a new clinical condition? Prevalence, predictors and outcome”. Antivir. Ther. (Lond.). 13 (1): 103β7. PMIDΒ 18389904.
- β 7.0 7.1 Nevens F, Fevery J, Van Steenbergen W, Sciot R, Desmet V, De Groote J (1990). “Arsenic and non-cirrhotic portal hypertension. A report of eight cases”. J. Hepatol. 11 (1): 80β5. PMIDΒ 2398270.
- β 8.0 8.1 Fuss IJ, Friend J, Yang Z, He JP, Hooda L, Boyer J, Xi L, Raffeld M, Kleiner DE, Heller T, Strober W (2013). “Nodular regenerative hyperplasia in common variable immunodeficiency”. J. Clin. Immunol. 33 (4): 748β58. doi:10.1007/s10875-013-9873-6. PMCΒ 3731765. PMIDΒ 23420139.
- β 9.0 9.1 Vaiphei K, Bhatia A, Sinha SK (2011). “Liver pathology in collagen vascular disorders highlighting the vascular changes within portal tracts”. Indian J Pathol Microbiol. 54 (1): 25β31. doi:10.4103/0377-4929.77319. PMIDΒ 21393872.
- β 10.0 10.1 De Boer NK, Tuynman H, Bloemena E, Westerga J, Van Der Peet DL, Mulder CJ, Cuesta MA, Meuwissen SG, Van Nieuwkerk CM, Van Bodegraven AA (2008). “Histopathology of liver biopsies from a thiopurine-naΓ―ve inflammatory bowel disease cohort: prevalence of nodular regenerative hyperplasia”. Scand. J. Gastroenterol. 43 (5): 604β8. doi:10.1080/00365520701800266. PMIDΒ 18415755.
- β 11.0 11.1 Sarin SK, Mehra NK, Agarwal A, Malhotra V, Anand BS, Taneja V (1987). “Familial aggregation in noncirrhotic portal fibrosis: a report of four families”. Am. J. Gastroenterol. 82 (11): 1130β3. PMIDΒ 3499813.
- β 12.0 12.1 Imai Y, Minami Y, Miyoshi S, Kawata S, Saito R, Noda S, Tamura S, Nishikawa M, Tajima K, Tarui S (1986). “Idiopathic portal hypertension associated with Hashimoto’s disease: report of three cases”. Am. J. Gastroenterol. 81 (9): 791β5. PMIDΒ 2944377.
- β 13.0 13.1 Siramolpiwat S, Seijo S, Miquel R, Berzigotti A, Garcia-Criado A, Darnell A, Turon F, Hernandez-Gea V, Bosch J, Garcia-PagΓ‘n JC (2014). “Idiopathic portal hypertension: natural history and long-term outcome”. Hepatology. 59 (6): 2276β85. doi:10.1002/hep.26904. PMIDΒ 24155091.
- β 14.0 14.1 de Lonlay P, Seta N (2009). “The clinical spectrum of phosphomannose isomerase deficiency, with an evaluation of mannose treatment for CDG-Ib”. Biochim. Biophys. Acta. 1792 (9): 841β3. doi:10.1016/j.bbadis.2008.11.012. PMIDΒ 19101627.
- β Allison MC, Mowat A, McCruden EA, McGregor E, Burt AD, Briggs JD, Junor BJ, Follett EA, MacSween RN, Mills PR (1992). “The spectrum of chronic liver disease in renal transplant recipients”. Q. J. Med. 83 (301): 355β67. PMIDΒ 1438671.
- β Gane E, Portmann B, Saxena R, Wong P, Ramage J, Williams R (1994). “Nodular regenerative hyperplasia of the liver graft after liver transplantation”. Hepatology. 20 (1 Pt 1): 88β94. PMIDΒ 8020909.
- β 17.0 17.1 Vernier-Massouille G, Cosnes J, Lemann M, Marteau P, Reinisch W, Laharie D, Cadiot G, Bouhnik Y, De Vos M, Boureille A, Duclos B, Seksik P, Mary JY, Colombel JF (2007). “Nodular regenerative hyperplasia in patients with inflammatory bowel disease treated with azathioprine”. Gut. 56 (10): 1404β9. doi:10.1136/gut.2006.114363. PMCΒ 2000290. PMIDΒ 17504943.
- β 18.0 18.1 Calabrese E, Hanauer SB (2011). “Assessment of non-cirrhotic portal hypertension associated with thiopurine therapy in inflammatory bowel disease”. J Crohns Colitis. 5 (1): 48β53. doi:10.1016/j.crohns.2010.08.007. PMIDΒ 21272804.
- β 19.0 19.1 Roulot D (2013). “Liver involvement in Turner syndrome”. Liver Int. 33 (1): 24β30. doi:10.1111/liv.12007. PMIDΒ 23121401.
- β 20.0 20.1 Geubel AP, De Galocsy C, Alves N, Rahier J, Dive C (1991). “Liver damage caused by therapeutic vitamin A administration: estimate of dose-related toxicity in 41 cases”. Gastroenterology. 100 (6): 1701β9. PMIDΒ 2019375.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Syed Hassan A. Kazmi BSc, MD [2]
